Find Milsaperidone manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

0

CEP/COS

0

JDMF

0

EU WC

0

KDMF

0

NDC API

0

VMF

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Europe

0

Canada

0

Australia

0

South Africa

0

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 501373-88-2, (s)-hydroxy iloperidone, Unii-7sv1zog031, 7sv1zog031, P-88-8991, (-)-, (s)-1-(4-{3-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-propoxy}-3-methoxy-phenyl)-ethanol
Molecular Formula
C24H29FN2O4
Molecular Weight
428.5  g/mol
InChI Key
SBKZGLWZGZQVHA-INIZCTEOSA-N
FDA UNII
7SV1ZOG031

Milsaperidone
1 2D Structure

Milsaperidone

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(1S)-1-[4-[3-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]propoxy]-3-methoxyphenyl]ethanol
2.1.2 InChI
InChI=1S/C24H29FN2O4/c1-16(28)18-4-7-21(23(14-18)29-2)30-13-3-10-27-11-8-17(9-12-27)24-20-6-5-19(25)15-22(20)31-26-24/h4-7,14-17,28H,3,8-13H2,1-2H3/t16-/m0/s1
2.1.3 InChI Key
SBKZGLWZGZQVHA-INIZCTEOSA-N
2.2 Other Identifiers
2.2.1 UNII
7SV1ZOG031
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 501373-88-2

2. (s)-hydroxy Iloperidone

3. Unii-7sv1zog031

4. 7sv1zog031

5. P-88-8991, (-)-

6. (s)-1-(4-{3-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-propoxy}-3-methoxy-phenyl)-ethanol

7. Milsaperidone (usan)

8. Milsaperidone [usan]

9. (1s)-1-[4-[3-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]propoxy]-3-methoxyphenyl]ethanol

10. Milsaperidone

11. Benzenemethanol, 4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxy-alpha-methyl-, (alphas)-

12. Milsaperidone [inn]

13. Schembl1566323

14. Vhx896

15. Vhx-896

16. Sbkzglwzgzqvha-inizcteosa-n

17. D13099

18. (-)-p-88-8991

19. Q27268802

20. (

21. As)-4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxy-

22. A-methylbenzenemethanol

23. (alphas)-4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxy-alpha-methylbenzenemethanol

24. (s)-1-(4-(3-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)propoxy)-3-methoxyphenyl)ethan-1-ol

25. (s)-1-[4-{3-[4-(6-fluoro-benzo(d)isoxazol-3-yl)-piperidin-1-yl]-propoxy}-3-methoxv-phenyl]-ethanol

26. (s)-1-[4-{3-[4-(6-fluoro-benzo(d)isoxazol-3-yl)-piperidin-1-yl]-propoxy}-3-methoxy-phenyl]ethanol

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 428.5 g/mol
Molecular Formula C24H29FN2O4
XLogP33.9
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count7
Rotatable Bond Count8
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area68
Heavy Atom Count31
Formal Charge0
Complexity548
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

API SUPPLIERS

read-more
read-more

01

Maithri Drugs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMaithri Drugs: Dedicated to your API needs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
Company Banner
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Milsaperidone, a miscellaneous product targeting 5-HT2A and D2 receptors, shows promise in treating bipolar I disorder.


Lead Product(s): Milsaperidone

Therapeutic Area: Psychiatry/Psychology Brand Name: Bysanti

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 21, 2026

blank

01

AMWC Asia-TDAC
Not Confirmed
AMWC Asia-TDAC
Not Confirmed

Details : Milsaperidone, a miscellaneous product targeting 5-HT2A and D2 receptors, shows promise in treating bipolar I disorder.

Product Name : Bysanti

Product Type : Miscellaneous

Upfront Cash : Inapplicable

February 21, 2026

blank

Details:

Bysanti (milsaperidone) is a small molecule being investigated for the treatments of acute bipolar I disorder and schizophrenia.


Lead Product(s): Milsaperidone

Therapeutic Area: Psychiatry/Psychology Brand Name: Bysanti

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable March 31, 2025

blank

02

AMWC Asia-TDAC
Not Confirmed
AMWC Asia-TDAC
Not Confirmed

Details : Bysanti (milsaperidone) is a small molecule being investigated for the treatments of acute bipolar I disorder and schizophrenia.

Product Name : Bysanti

Product Type : Miscellaneous

Upfront Cash : Inapplicable

March 31, 2025

blank

Details:

Milsaperidone is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Depressive Disorder, Major.


Lead Product(s): Milsaperidone

Therapeutic Area: Psychiatry/Psychology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 17, 2025

blank

03

AMWC Asia-TDAC
Not Confirmed
AMWC Asia-TDAC
Not Confirmed

Details : Milsaperidone is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Depressive Disorder, Major.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

February 17, 2025

blank

Details:

VHX-896 is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): Milsaperidone,Inapplicable

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Undisclosed

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 31, 2025

blank

04

AMWC Asia-TDAC
Not Confirmed
AMWC Asia-TDAC
Not Confirmed

Details : VHX-896 is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

January 31, 2025

blank

Details:

VHX-896 is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Schizophrenia.


Lead Product(s): Milsaperidone,Iloperidone

Therapeutic Area: Psychiatry/Psychology Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Undisclosed

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 10, 2024

blank

05

AMWC Asia-TDAC
Not Confirmed
AMWC Asia-TDAC
Not Confirmed

Details : VHX-896 is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Schizophrenia.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

July 10, 2024

blank

Details:

VHX-896 is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): Milsaperidone,Iloperidone

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Undisclosed

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 20, 2021

blank

06

AMWC Asia-TDAC
Not Confirmed
AMWC Asia-TDAC
Not Confirmed

Details : VHX-896 is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

July 20, 2021

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

read-more
read-more

01

arrow
AMWC Asia-TDAC
Not Confirmed
arrow
AMWC Asia-TDAC
Not Confirmed

MILSAPERIDONE

US Patent Number : 10563259

Drug Substance Claim :

Drug Product Claim :

Application Number : 220358

Patent Use Code : U-4437

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-07-24

blank

02

arrow
AMWC Asia-TDAC
Not Confirmed
arrow
AMWC Asia-TDAC
Not Confirmed

MILSAPERIDONE

US Patent Number : 8999638

Drug Substance Claim :

Drug Product Claim :

Application Number : 220358

Patent Use Code : U-4437

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-10-28

blank

03

arrow
AMWC Asia-TDAC
Not Confirmed
arrow
AMWC Asia-TDAC
Not Confirmed

MILSAPERIDONE

US Patent Number : 9074255

Drug Substance Claim :

Drug Product Claim :

Application Number : 220358

Patent Use Code : U-4436

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-12-17

blank

04

arrow
AMWC Asia-TDAC
Not Confirmed
arrow
AMWC Asia-TDAC
Not Confirmed

MILSAPERIDONE

US Patent Number : 10563259

Drug Substance Claim :

Drug Product Claim :

Application Number : 220358

Patent Use Code : U-4436

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-07-24

blank

05

arrow
AMWC Asia-TDAC
Not Confirmed
arrow
AMWC Asia-TDAC
Not Confirmed

MILSAPERIDONE

US Patent Number : 8999638

Drug Substance Claim :

Drug Product Claim :

Application Number : 220358

Patent Use Code : U-4436

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-10-28

blank

06

arrow
AMWC Asia-TDAC
Not Confirmed
arrow
AMWC Asia-TDAC
Not Confirmed

MILSAPERIDONE

US Patent Number : 9074256

Drug Substance Claim :

Drug Product Claim :

Application Number : 220358

Patent Use Code : U-4436

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-02-10

blank

07

arrow
AMWC Asia-TDAC
Not Confirmed
arrow
AMWC Asia-TDAC
Not Confirmed

MILSAPERIDONE

US Patent Number : 9074255

Drug Substance Claim :

Drug Product Claim :

Application Number : 220358

Patent Use Code : U-4437

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-12-17

blank

08

arrow
AMWC Asia-TDAC
Not Confirmed
arrow
AMWC Asia-TDAC
Not Confirmed

MILSAPERIDONE

US Patent Number : 10570453

Drug Substance Claim :

Drug Product Claim :

Application Number : 220358

Patent Use Code : U-4436

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-03-28

blank

09

arrow
AMWC Asia-TDAC
Not Confirmed
arrow
AMWC Asia-TDAC
Not Confirmed

MILSAPERIDONE

US Patent Number : 9072742

Drug Substance Claim :

Drug Product Claim :

Application Number : 220358

Patent Use Code : U-4437

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-01-16

blank

10

arrow
AMWC Asia-TDAC
Not Confirmed
arrow
AMWC Asia-TDAC
Not Confirmed

MILSAPERIDONE

US Patent Number : 9074256

Drug Substance Claim :

Drug Product Claim :

Application Number : 220358

Patent Use Code : U-4436

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-02-10

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Looking for 501373-88-2 / Milsaperidone API manufacturers, exporters & distributors?

Milsaperidone manufacturers, exporters & distributors 1

74

PharmaCompass offers a list of Milsaperidone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Milsaperidone manufacturer or Milsaperidone supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Milsaperidone manufacturer or Milsaperidone supplier.

API | Excipient name

Milsaperidone

Synonyms

501373-88-2, (s)-hydroxy iloperidone, Unii-7sv1zog031, 7sv1zog031, P-88-8991, (-)-, (s)-1-(4-{3-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-propoxy}-3-methoxy-phenyl)-ethanol

Cas Number

501373-88-2

Unique Ingredient Identifier (UNII)

7SV1ZOG031

Milsaperidone Manufacturers

A Milsaperidone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Milsaperidone, including repackagers and relabelers. The FDA regulates Milsaperidone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Milsaperidone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Milsaperidone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Milsaperidone Suppliers

A Milsaperidone supplier is an individual or a company that provides Milsaperidone active pharmaceutical ingredient (API) or Milsaperidone finished formulations upon request. The Milsaperidone suppliers may include Milsaperidone API manufacturers, exporters, distributors and traders.

click here to find a list of Milsaperidone suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Milsaperidone GMP

Milsaperidone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Milsaperidone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Milsaperidone GMP manufacturer or Milsaperidone GMP API supplier for your needs.

Milsaperidone CoA

A Milsaperidone CoA (Certificate of Analysis) is a formal document that attests to Milsaperidone's compliance with Milsaperidone specifications and serves as a tool for batch-level quality control.

Milsaperidone CoA mostly includes findings from lab analyses of a specific batch. For each Milsaperidone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Milsaperidone may be tested according to a variety of international standards, such as European Pharmacopoeia (Milsaperidone EP), Milsaperidone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Milsaperidone USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty